Filana Therapeutics (FLNA) Goodwill & Intangibles (2020 - 2024)
Filana Therapeutics (FLNA) posted quarterly Goodwill & Intangibles of $37000.0 for Q4 2024, down 78.98% year-over-year from $176000.0 in Q1 2024, and down 46.38% quarter-over-quarter from $69000.0 in Q3 2024.
Filana Therapeutics (FLNA) Goodwill & Intangibles (2020 - 2024) Analysis & Trends
Filana Therapeutics' Goodwill & Intangibles history runs 5 years deep, the most recent figure standing at $37000.0 for Q4 2024.
- In Q4 2024, Goodwill & Intangibles fell 78.98% year-over-year to $37000.0; the TTM figure through Dec 2024 stood at $37000.0 (down 78.98% YoY), while the FY2024 annual figure was $37000.0, down 78.98% from the prior year.
- Goodwill & Intangibles for Q4 2024 stood at $37000.0, down from $69000.0 in the prior quarter.
- The five-year high for Goodwill & Intangibles was $1.3 million in Q3 2022, with the low at $37000.0 in Q4 2024.
- The 5-year median for Goodwill & Intangibles is $503000.0 (2023), against an average of $604933.3.
- The sharpest annual moves came in 2022 and 2023: Goodwill & Intangibles climbed 3.39% in 2022, then slumped 80.04% in 2023.
- Filana Therapeutics' Goodwill & Intangibles stood at $1.3 million in 2020, then decreased by 17.24% to $1.1 million in 2021, then slumped by 42.14% to $622000.0 in 2022, then slumped by 71.7% to $176000.0 in 2023, then slumped by 78.98% to $37000.0 in 2024.
- Business Quant data shows FLNA's Goodwill & Intangibles at $37000.0 in Q4 2024, $69000.0 in Q3 2024, and $82000.0 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Filana Therapeutics | 46.00 Mn | 46.00 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 37,000.00 |
| Sep 30, 2024 | 69,000.00 |
| Jun 30, 2024 | 82,000.00 |
| Mar 31, 2024 | 115,000.00 |
| Dec 31, 2023 | 176,000.00 |
| Sep 30, 2023 | 268,000.00 |
| Jun 30, 2023 | 387,000.00 |
| Mar 31, 2023 | 503,000.00 |
| Dec 31, 2022 | 622,000.00 |
| Sep 30, 2022 | 1.34 Mn |
| Jun 30, 2022 | 859,000.00 |
| Mar 31, 2022 | 940,000.00 |
| Dec 31, 2021 | 1.08 Mn |
| Sep 30, 2021 | 1.30 Mn |
| Dec 31, 2020 | 1.30 Mn |